Please login to the form below

Not currently logged in

Charles River ties up with Theorem for non-clinical testing

CROs form strategic alliance in bioanalysis, immunogenicity and immunology

Charles River Laboratories and Theorem Clinical Research have formed a strategic alliance to provide their clients with a new non-clinical testing and analysis service.

The US clinical research organisations' (CRO) alliance covers bioanalysis, immunogenicity and immunology programmes to support trials running all the way up to product registration.

Alan Bartlett, executive director of laboratory services, Charles River Laboratories: “We are pleased to partner with a world-class clinical trials organization like Theorem Clinical Research. Sponsors will benefit from the experience of both organisations. The alliance will offer a seamless transition from preclinical testing into the clinical arena.”

For Theorem the deal caps a busy few months that have seen it look to expand its network by signing a series of strategic alliances. Since July it has tied up with medical product development firm Ximedica, medical imaging company RadMD and regulatory consultancy the Emergo Group.

Article by
Dominic Tyer

17th September 2013

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Australian Flu and the dilemma of naming diseases
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....